CCR5 — Drug Target

All drugs that target CCR5 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

CCR5 antagonist

Phase 3 pipeline (1)

• Celsentri® · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · CCR5 antagonist · Infectious Disease
  Celsentri is a CCR5 antagonist that blocks the CCR5 co-receptor on CD4+ T cells, preventing HIV entry and infection.

Phase 2 pipeline (1)

• HIV Anti-retroviral Background Therapy · Theratechnologies · CCR5 antagonist · Infectious Disease
  Inhibits HIV replication by targeting the CCR5 receptor